Certificati di investimento - Cap. 4

[FNAIOS]

Vedi l'allegato 613180

L'avevo detto io che i KIDs non contanto niente.
Stanno lì per bellezza.
Ti ci pulisci il cruscotto.

 

[Fedex71]

Ciao a tutti, sono usciti i dati di bilancio di Biogen? In teoria era ieri...ma non v'è traccia...

 

[Fabrib]

Ciao a tutti, sono usciti i dati di bilancio di Biogen? In teoria era ieri...ma non v'è traccia...

Jul. 22, 2021

• Despite declining sales in its key therapeutics in the portfolio, Biogen (NASDAQ:BIIB) has raised the full-year revenue forecast on the back of recent FDA approval of the company’s Alzheimer’s medication, ADUHELM.
• Biogen shares have added ~1.4% in the pre-market after revenue and non-GAAP earnings exceeded the consensus forecasts.
• Compared to the 23.8% YoY decline in Q1 2021, the revenue for Q2 2021 has dropped 25% YoY to $2.8B as sales from multiple sclerosis therapy TECFIDERA dropped 58.7% YoY compared to 56.4% YoY decline in the previous quarter.
• The sales from spinal muscular atrophy therapy SPINRAZA increased 1% YoY reversing the 7.9% YoY decline recorded in the previous quarter.
• After winning FDA approval in June, the company has posted $2M in revenue for Alzheimer’s medication, ADUHELM.
• Diluted earnings per share during Q2 2021 were $2.99 on a GAAP basis compared to $2.69 in Q1 2021.
• Despite a modest sales impact from ADUHELM and the continuing erosion of TECFIDERA and RITUXAN sales in the U.S., Biogen has raised 2021 full-year guidance to $10.65B to $10.85B from the previous projection of $10.45B to $10.75B.
• However, the forecast for non-GAAP diluted EPS remained unchanged at $17.50 to $19.00 indicating higher R&D and SG&A expenses in H2 2021 due to collaborations, data readouts, and investments in ADUHELM, Biogen said.
• Commenting on results, CEO Michel Vounatsos said: “We were pleased with our operational performance in the second quarter.”
• “We look forward to the expected Phase 3 data for tofersen, the first genetically-targeted potential therapy for ALS, for which we have begun offering individual compassionate use access,” Vounatsos added.
• The consensus estimates for Biogen indicate ~$10.6B in revenue for the company in 2021.

 

[Fabrib]

LONDON (Reuters) -All of Monte dei Paschi's capital was wiped out in a European Union stress test of banks on Friday as the Italian lender headed for government-sponsored merger talks with domestic peer UniCredit, whose own score fell short of the sector's aggregate performance.
The exercise by the European Banking Authority showed that EU banks took a 265 billion euro ($314.7 billion) hit in a test of their resilience to economic shocks, which still left them with two-thirds of their buffers intact
The EBA tested the resilience of 50 top lenders to economic shocks, though there is no formal pass or fail mark. The banks account for 70% of EU banking assets
Under the harshest scenario spanning three years to 2023, which baked in a prolonged fallout from COVID, the aggregate core ratio of capital to risk-weighted assets fell by nearly 500 basis points, pushing the ratio down to 10.2% from 15%.
Monte dei Paschi, however, ended the test with a core capital ratio of minus 0.1% under the adverse scenario. UniCredit came in at 9.
Monte dei Paschi fared worst in the EU's stress test five years ago, in a sign of how deep-rooted problems at the world's oldest bank have yet to be sorted out.
None of the Italian banks tested, the others were Mediobanca, Banco BPM and Intesa Sanpaolo, reached the 10% sector aggregate though several were very close.
Sweden's banks were all above 10%, with Skandinaviska Enskilda Banken at 17.4%
Investment banks Deutsche Bank and Societe Generale, in the midst of turnarounds, both performed below average under the adverse scenario, with scores of 7.56% and 7.73%, respectively. BNP Paribas came in at 8.28%, with Commerzbank at 8.52%.
"This outcome is all the more encouraging because the strong profit growth we delivered in the first half of 2021 is not reflected in this exercise," said Deutsche's chief financial officer, James von Moltke.
Just one of four Spanish banks tested, Bankinter, was above 10%.
The results of the tests, which were delayed from last year due to COVID-19, are seen as critical to banks resuming dividend payouts, which were barred during the pandemic in order to conserve capital.
"Since the start of COVID, there has been a problem of visibility of banks' relative asset quality. This stress test will increase transparency across the industry," said Javier Garcia, a partner at consultants Oliver Wyman.

 

[NoWay]

LONDON (Reuters) -All of Monte dei Paschi's capital was wiped out in a European Union stress test of banks on Friday as the Italian lender headed for government-sponsored merger talks with domestic peer UniCredit, whose own score fell short of the sector's aggregate performance.
The exercise by the European Banking Authority showed that EU banks took a 265 billion euro ($314.7 billion) hit in a test of their resilience to economic shocks, which still left them with two-thirds of their buffers intact
The EBA tested the resilience of 50 top lenders to economic shocks, though there is no formal pass or fail mark. The banks account for 70% of EU banking assets
Under the harshest scenario spanning three years to 2023, which baked in a prolonged fallout from COVID, the aggregate core ratio of capital to risk-weighted assets fell by nearly 500 basis points, pushing the ratio down to 10.2% from 15%.
Monte dei Paschi, however, ended the test with a core capital ratio of minus 0.1% under the adverse scenario. UniCredit came in at 9.
Monte dei Paschi fared worst in the EU's stress test five years ago, in a sign of how deep-rooted problems at the world's oldest bank have yet to be sorted out.
None of the Italian banks tested, the others were Mediobanca, Banco BPM and Intesa Sanpaolo, reached the 10% sector aggregate though several were very close.
Sweden's banks were all above 10%, with Skandinaviska Enskilda Banken at 17.4%
Investment banks Deutsche Bank and Societe Generale, in the midst of turnarounds, both performed below average under the adverse scenario, with scores of 7.56% and 7.73%, respectively. BNP Paribas came in at 8.28%, with Commerzbank at 8.52%.
"This outcome is all the more encouraging because the strong profit growth we delivered in the first half of 2021 is not reflected in this exercise," said Deutsche's chief financial officer, James von Moltke.
Just one of four Spanish banks tested, Bankinter, was above 10%.
The results of the tests, which were delayed from last year due to COVID-19, are seen as critical to banks resuming dividend payouts, which were barred during the pandemic in order to conserve capital.
"Since the start of COVID, there has been a problem of visibility of banks' relative asset quality. This stress test will increase transparency across the industry," said Javier Garcia, a partner at consultants Oliver Wyman.

Quindi, anche in caso di catastrofe nucleare, il sistema bancario europeo terrebbe... non l'avrei mai detto...

 

[valgri]

Postato da utente Abulico in altra sezione del Forum

COMUNICATO STAMPA

BMPS: RISULTATI STRESS TEST EBA 2021

https://www.gruppomps.it/static/upload/cs_/cs_30_07_21_ita.pdf

 

[gianni76]

Tutti i risultati sono qui:

EU-wide stress testing | European Banking Authority

www.eba.europa.eu

Le banche italiane non vanno benissimo nello scenario sotto stress per il solito motivo dei crediti deteriorati...
Qui un breve sommario:

Nello scenario avverso Mediobanca è la migliore, il coefficiente patrimoniale Common Equity Tier 1 ratio (CET1 ratio) risultante dallo stress test al 2023, anno finale della simulazione, è 17,19% secondo i criteri transitori, in vigore per il 2023, e 15,79% secondo i criteri a regime, nello scenario base; 11,49% secondo i criteri transitori, in vigore per il 2023, e 9,73% secondo i criteri a regime, nello scenario avverso.

Per Intesa Sanpaolo è pari a 15,06% nello scenario base e 9,38% nello scenario avverso rispetto al dato di partenza pari a 14,04%.

Unicredit nello scenario di base ha un Cet1 fully loaded al 15,66% (15,80% con i criteri transitori) e nello scenario avverso al 9,22% (9,59% secondo i criteri transitori).

Banco Bpm vede ridursi il Cet 1 ratio fully loaded post impatto Stress Test Baseline scenario al 14,67% e con lo scenario avverso al 7,01% al 2023 dal 13,23% di fine 2020.

Mps, si diceva, ha registrato il peggior risultato tra le 50 banche europee sottoposte dall’Eba allo stress test. L’istituto senese, nello scenario avverso, vede il suo Cet1 ratio, principale indicatore di solidità patrimoniale, ridursi di 996 punti base passando dal 9,86% di fine 2020 a -0,1% del 2023.

 

[percefal]

Il valore della privacy L'autorità lussemburghese per la protezione dei dati ha inflitto una multa record ad Amazon da 746 milioni di euro per violazione delle norme Ue sulla privacy. Il colosso dell'ecommerce ha già annunciato ricorso (Il Sole 24 Ore). Secondo Bloomberg il conseguente tonfo in Borsa sarebbe costato al patrimonio di Jeff Bezos oltre 13 miliardi di dollari.

 

[NoWay]

Tutti i risultati sono qui:

EU-wide stress testing | European Banking Authority

www.eba.europa.eu

Le banche italiane non vanno benissimo nello scenario sotto stress per il solito motivo dei crediti deteriorati...
Qui un breve sommario:

Nello scenario avverso Mediobanca è la migliore, il coefficiente patrimoniale Common Equity Tier 1 ratio (CET1 ratio) risultante dallo stress test al 2023, anno finale della simulazione, è 17,19% secondo i criteri transitori, in vigore per il 2023, e 15,79% secondo i criteri a regime, nello scenario base; 11,49% secondo i criteri transitori, in vigore per il 2023, e 9,73% secondo i criteri a regime, nello scenario avverso.

Per Intesa Sanpaolo è pari a 15,06% nello scenario base e 9,38% nello scenario avverso rispetto al dato di partenza pari a 14,04%.

Unicredit nello scenario di base ha un Cet1 fully loaded al 15,66% (15,80% con i criteri transitori) e nello scenario avverso al 9,22% (9,59% secondo i criteri transitori).

Banco Bpm vede ridursi il Cet 1 ratio fully loaded post impatto Stress Test Baseline scenario al 14,67% e con lo scenario avverso al 7,01% al 2023 dal 13,23% di fine 2020.

Mps, si diceva, ha registrato il peggior risultato tra le 50 banche europee sottoposte dall’Eba allo stress test. L’istituto senese, nello scenario avverso, vede il suo Cet1 ratio, principale indicatore di solidità patrimoniale, ridursi di 996 punti base passando dal 9,86% di fine 2020 a -0,1% del 2023.

Mah... al di là di MPS (che è decotta da anni e che sta in piedi perchè deve) a me sembra che non siano poi così male. L'Eba stessa parla di simulazione "under a very severe scenario", roba appunto da armageddon...

 

[NoWay]

Aggiornamento file (era pure ora... )

DISCLAIMER (post CS): Ci potrebbero essere degli errori, anzi ci saranno sicuramente. Prima di investire, controllate i Final Terms ufficiali.